01
Cancer Immunotherapy
Advanced checkpoint inhibitors and combination therapies for solid tumors and blood cancers.
- PD-1 / PD-L1 inhibitors
- Dual immunotherapy strategies
- Immune-related AE management
What I treat
Specializations
Evidence-based oncology care across a full spectrum of cancers, from diagnosis to systemic therapy.
01Standard
Treatment decided by the tumour’s biology,
not by its label.
Six areas carry the practice — from immunotherapy and targeted therapy to the surrounding spectrum of solid tumours and haematological malignancy. Every plan is drawn from staging, molecular profiling and the published evidence behind it, and reviewed at a multidisciplinary tumour board before treatment begins.
02Specializations
Areas of practice
Six areas carry the practice. The first is where most referrals begin; the rest is the spectrum of solid tumours and haematological malignancy around it.
-
02
Targeted Therapy
Precision-guided treatments focusing on molecular drivers and individual tumor biology.
- EGFR, ALK, ROS1 rearrangements
- HER2+ breast cancer protocols
- CDK4/6 inhibitor expertise
-
03
Personalized Oncology
Utilizing next-generation sequencing and liquid biopsies to personalize treatment strategies.
- Genomic tumor profiling
- Liquid biopsy monitoring
- Biomarker-guided therapy
-
04
Breast & Lung Cancer
Comprehensive management of breast and lung malignancies with the latest systemic protocols.
- Neoadjuvant chemotherapy
- Stage III NSCLC management
- Precision metastatic care
-
05
GI Oncology
Specialized care for gastrointestinal cancers using multidisciplinary evidence-based protocols.
- Colon & Rectal cancers
- Hepato-Pancreato-Biliary
- Esophageal & Gastric care
-
06
Lymphomas
Management of Hodgkin and Non-Hodgkin lymphomas with modern systemic and biological therapies.
- B-cell & T-cell Lymphomas
- Hodgkin's Disease
- Survivorship planning
03Approach
Treatment approach
Every plan follows the same four movements, from staging through to continuous review.
-
01
Assessment
Thorough review of staging and molecular profiling.
-
02
Multidisciplinary
Collaborative Tumor Board for consensus planning.
-
03
Evidence-Based
Rooted in global ESMO and ASCO guidelines.
-
04
Monitoring
Continuous response evaluation throughout care.
04Consultation
Discuss your treatment plan
Bring a diagnosis, a staging report or a question about an ongoing plan. Consultations are held at Bhagwan Mahaveer Jain Hospital, Vasanth Nagar, Bengaluru.